IVIg Plus Low Dose rhTPO for ITP in Pregnancy

Clinical trial NCT05634824 · UNKNOWN

Trial details

NCT number: NCT05634824
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia Pregnancy Related

Start date: 2023-01-01
Primary completion: 2023-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.